Previous 10 | Next 10 |
Shares of InspireMD Inc. (NYSE American:NSPR) traded at a new 52-week high today of $7.32. So far today approximately 8.8 million shares have been exchanged, as compared to an average 30-day volume of 5.6 million shares. InspireMD Inc is the United States based medical device company. It...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Amazon (NASDAQ: AMZN ) stock is rallying higher on Tuesday after speculative Tweets about a possible stock split sent shares soaring on Monday. Source: Quisquilia / Shutterstock.com The Tweets in question come f...
InspireMD (NSPR) has lost ~20.3% in the pre-market as the company shares begin trading on NYSE American on a split-adjusted basis.Meanwhile, NYSE Arca has reportedly canceled some early morning trades for the stock below $5.88. The exchange identified them as erroneous trades executed be...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips If you stumbled upon this morning’s more-than-1,000% jump in the price of InspireMD (NYSEMKT: NSPR ) stock on top of an even-bigger gain on Monday, allow us to unpack things for you. Today’s the day that...
InspireMD (NSPR) -19%.Reviva Pharmaceuticals (RVPH) -17%.RealNetworks RNWK -16% on preliminary estimates for its first-quarter, stock offering.Mechanical Technology (MKTY) -10% after subsidiary announces newest addition of the PBS-4100+ portable vibration and balancing system.S...
InspireMD (NSPR) shareholders have approved a 1:15 reverse stock split that will reduce the number of outstanding shares from 118M to 7.9M.The split takes effects after market close on April 26.The company also says it submitted an application to list on Nasdaq. InspireMD currently lists on N...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Welcome back traders as we start off another week of investing! We’re taking a look at the top pre-market movers for Monday morning, which includes both the winners and losers on the stock market. Source: oneinch...
TEL AVIV, Israel, April 19, 2021 (GLOBE NEWSWIRE) -- InspireMD, Inc. (NYSE American: NSPR, NSPR.WS, NSPR.WSB), developer of the CGuard™ Embolic Prevention System (EPS) for the prevention of stroke caused by the treatment of Carotid Artery Disease (CAD), today provided an update of re...
3 Penny Stocks to Watch As April Turns the Corner Penny stocks have performed quite well in April 2021. While volume is relatively low compared to previous months, we are seeing a great deal of bullish momentum right now. There are a few reasons why this is the case. First of all, C...
The Hottest Penny Stock Trends And How to Use Them to Your Advantage Penny stocks are the talk of the town and for good reason. Throughout 2020 and 2021, investors have been searching high and low to find the best penny stocks to watch . And while some traders are more experienced t...
News, Short Squeeze, Breakout and More Instantly...
-Conference call and webcast to be held at 8:30 a.m. EDT- TEL AVIV, Israel, and MIAMI, July 30, 2024 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR), developer of the CGuard™ Embolic Prevention Stent System (EPS) device for the treatment of Carotid Artery Disease and stroke prev...
Series H warrants exercisable following release of positive outcomes results related to one-year follow-up from the Company’s C-GUARDIANS pivotal trial. Participating warrant holders include Marshall Wace, OrbiMed, Rosalind, Nantahala, Soleus, Velan, and certain InspireMD Board m...
Data demonstrate lowest reported primary endpoint event rate of 1.95% through twelve months post-procedure for any carotid stent or embolic protection device pivotal trial Study results to support a Premarket Approval (PMA) application to FDA in H2 2024 U.S. commercial launch of...